TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review

被引：19
|
作者：
Sakai, Kazuya [1 ]
Maeda, Takeshi [1 ]
Kuriyama, Akira [2 ]
Shimada, Noriaki [3 ]
Notohara, Kenji [4 ]
Ueda, Yasunori [1 ]
机构：
[1] Kurashiki Cent Hosp, Dept Haematol Oncol, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan
[2] Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama, Japan
[3] Kurashiki Cent Hosp, Dept Nephrol, Kurashiki, Okayama, Japan
[4] Kurashiki Cent Hosp, Dept Anat Pathol, Kurashiki, Okayama, Japan
来源：
MODERN RHEUMATOLOGY | 2018年 / 28卷 / 03期
关键词：
Castleman's disease; Liver injury; Systematic review; Thrombocytopenia; anasarca; fever; reticulin fibrosis; and organomegaly syndrome; Tocilizumab; MULTICENTRIC CASTLEMANS-DISEASE; IDIOPATHIC PLASMACYTIC LYMPHADENOPATHY; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; CYCLOSPORINE-A; THROMBOCYTOPENIA; ANASARCA; MYELOFIBROSIS; ASCITES; FEVER; CONSTELLATION;
D O I：
10.3109/14397595.2015.1120389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is considered as a unique clinicopathologic variant of multicentric Castleman's disease and is recently reported in Japan. This entity represents a severe inflammatory state leading to organ failures such as severe liver dysfunction seen in our case, and can be treated by immunosuppressive agents, steroids, and cyclosporine shown in several case reports. A systematic review and our case suggest the potential utility of tocilizumab as a treatment for TAFRO syndrome.
引用
收藏
页码：564 / 569
页数：6
相关论文
共 50 条
  • [31] Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy
    Shunichiro Yasuda
    Keisuke Tanaka
    Ayako Ichikawa
    Ken Watanabe
    Emi Uchida
    Masahide Yamamoto
    Kouhei Yamamoto
    Daisuke Mizuchi
    Osamu Miura
    Tetsuya Fukuda
    International Journal of Hematology, 2016, 104 : 512 - 518
  • [32] Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab
    Kei Suzuki
    Takeshi Matsumoto
    Yoshiaki Iwashita
    Ken Ishikura
    Masaki Fujioka
    Hideo Wada
    Naoyuki Katayama
    Hiroshi Imai
    International Journal of Hematology, 2019, 109 : 737 - 743
  • [33] Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature
    Ryosuke Saiki
    Kan Katayama
    Yosuke Hirabayashi
    Keiko Oda
    Mika Fujimoto
    Tomohiro Murata
    Ayako Nakajima
    Kaoru Dohi
    BMC Nephrology, 22
  • [34] Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature
    Saiki, Ryosuke
    Katayama, Kan
    Hirabayashi, Yosuke
    Oda, Keiko
    Fujimoto, Mika
    Murata, Tomohiro
    Nakajima, Ayako
    Dohi, Kaoru
    BMC NEPHROLOGY, 2021, 22 (01)
  • [35] Renal histological continuum of TAFRO syndrome: A case report and literature review
    Uemura, Takayuki
    Matsui, Masaru
    Kokubu, Maiko
    Samejima, Ken-ich
    Tsuruya, Kazuhiko
    CLINICAL NEPHROLOGY, 2022, 97 (02) : 121 - 128
  • [36] TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review
    Yoshikuni Nagayama
    Mizuki Yamano
    Motoka Yagame
    Tomoyuki Nariyama
    Mikiko Takahashi
    Masashi Kawamoto
    Katsuyuki Matsui
    BMC Nephrology, 20
  • [37] Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab
    Suzuki, Kei
    Matsumoto, Takeshi
    Iwashita, Yoshiaki
    Ishikura, Ken
    Fujioka, Masaki
    Wada, Hideo
    Katayama, Naoyuki
    Imai, Hiroshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (06) : 737 - 743
  • [38] OxaliplatinHyperexcitability syndrome successfully treated with pregabalin: case report
    Reactions Weekly, 2008, 1187 (1) : 21 - 21
  • [39] TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review
    Nagayama, Yoshikuni
    Yamano, Mizuki
    Yagame, Motoka
    Nariyama, Tomoyuki
    Takahashi, Mikiko
    Kawamoto, Masashi
    Matsui, Katsuyuki
    BMC NEPHROLOGY, 2019, 20 (01)
  • [40] Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab
    Wakiya, Risa
    Kameda, Tomohiro
    Takeuchi, Yohei
    Ozaki, Hiroki
    Nakashima, Shusaku
    Shimada, Hiromi
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    MODERN RHEUMATOLOGY CASE REPORTS, 2021, 5 (01) : 145 - 151
12345